Examedi

Examedi

Private
Santiago, Región Metropolitana de SantiagoHealthcare & Life Scienceshttps://www.examedi.com

Last Round

Series A

Jun 22, 2022

Total Funding Raised

$20.5M

Momentum Score

50 /100

Company Overview

Examedi is a health-tech company that operates a telemedicine platform for at-home medical services in Latin America. The company connects patients with nurses and medical staff for services such as diagnostic tests, blood work, vaccinations, and general checkups, with samples being processed by partner laboratories. Initially focused on at-home PCR tests during the COVID-19 pandemic, Examedi has since expanded its offerings to include telemedicine, kinesiology, nutrition, and mental health services. The company aims to make healthcare more accessible and affordable by using a logistics model similar to on-demand delivery apps. After participating in Y Combinator's Summer 2021 cohort, Examedi raised a $17 million Series A round in June 2022, led by General Catalyst, to fund product development and geographic expansion. The company is also integrating artificial intelligence to provide users with simplified interpretations of their medical results and personalized health recommendations.

Sector

Healthcare & Life Sciences

Verticals

Last-Mile Delivery, Telemedicine, Logistics Software

Business Model

B2C

Customer Profile

Marketplace Commission, Services & Consulting

AI Layer

Non-AI

Keywords

at-home medical testshealthcare marketplacetelemedicineLatAm health techon-demand healthcaremedical house callsat-home healthcaremobile phlebotomyhealth techvirtual caremedical sample collectionhealthcare logisticsat-home physical therapyat-home vaccinationsat-home ECGB2B healthcare services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Examedi Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Examedi Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 22, 2022
SeedSep 20, 2021
AcceleratorMar 1, 2021

Key People

Founding team and executive leadership

Andrés Kemeny

Co-Founder CTO

Founding Team

Felipe Flores

CEO Co-Founder

Founding Team

Mariano Werner

CEO

Executive Team

Matías M.

Chief Financial Officer

Executive Team

Examedi Investors

Notable investors and investment history

InvestorRounds
Goodwater CapitalSeed
General CatalystSeries A
Y CombinatorSeed
Platanus VenturesSeries A, Seed, Accelerator
8VCSeed
Quiet CapitalSeed

Examedi Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Examedi Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Examedi's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago, Región Metropolitana de Santiago
Employee Range70
Year Founded2021
Last FundingJun 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.